Bayer fully ‘confident and determined’ in China
Print Edition
Bayer, the life science company, stands ready to offer more innovative products and solutions to cater to China’s booming and evolving domestic demand. It said its confidence and determination to establish its roots in China follows the Chinese government’s work report and remarks during the annual sessions of the national legislature and political advisory body.
The NPC & CPPCC, which wrapped up last week, have laid a solid foundation for building an overall moderately prosperous society, Bayer said.
They had unfolded a number of measures for attaining stable growth and raising living standards and also vowed to strengthen construction of the public health system and adhere to the principle of according high importance to people’s lives, and promoting a higher level of opening up to the outside world to promote reforms and developments.
“As one of the first multinational enterprises entering the Chinese market, Bayer is highly encouraged by the positive signals conveyed by the central government at the NPC & CPPCC,” said Jiang Wei, executive vice president and president, Bayer Pharmaceuticals Region China & APAC; president, Bayer Group China. “Bayer will continue to stick to its vision of ‘health for all, hunger for none’ and keep firmly rooted in China.
“We will continue to strive to meet the needs of China’s healthcare and food supply with innovative products and solutions, shouldering corporate social responsibilities, empowering Chinese people to create a better life, and contributing to China’s goals of building a moderately prosperous society catering to all spheres of life and winning the ‘poverty alleviation battle.’”
Bayer has been keeping pace with the Chinese government, actively providing integrated solutions for prevention, diagnosis and treatment, and helping to combat the COVID-19 pandemic with practical action since the outbreak.
Bayer has been taking comprehensive measures to resume work in an orderly manner, reducing the negative impact on production and the supply chain, and striving to ensure business continuity so as to provide products that are urgently needed by patients, consumers and growers and at the same time doing its best to protect the safety of its employees.
The stable development of Chinese society supports Bayer with fundamental assurance for its production and operation activities in China, and enhances Bayer’s confidence and determination to invest further in China.
Bayer highly appreciates supporting policies presented by the Chinese government for stabilizing foreign investment and foreign trade, as well as the determination of the Chinese government to continue reform and opening-up.
Bayer believes that in the upcoming year and for long-term future development, health care and agriculture will continue to occupy a crucial position, and it stands ready to make contributions to improve people’s health and nutrition through innovation and cooperation based on experience accumulated in China.
It also believes COVID-19 will accelerate the construction and improvement of China’s public health care system to create more encouraging policies and programs to promote collaboration in medical innovations that are likely to be rolled out.
Bayer will seize the development opportunity to accelerate the introduction of innovative products, deepen local innovation collaboration, actively respond to and support national policies, improve drug access and effectively alleviate patients’ financial burden.
As more people are realizing the significance of improving their immune system and place emphasis on active prevention rather than passive medical treatment, Bayer will continue to provide Chinese consumers with leading over-the-counter drugs, dietary supplements and other self-care solutions.
It also seeks to further cooperate with the government and industrial organizations to popularize scientific knowhow, besides remaining committed to promoting public awareness of self-care, and to offer more health-related education to Chinese consumers.
In agriculture, Bayer will continue to respond to the state’s call and best utilize its innovative advantages to help building an overall moderately prosperous society.
Bayer is committed to promoting scientific and technological plant protection to vigorously prevent and control major diseases and insect pests, and at the same time further develop integrated solutions of “Bayer Much More” to field crops and “Bayer Much Better” to horticulture crops tailored for the Chinese market.
As always, China will remain an indispensable partner for Bayer thanks to the gradually improving business environment, continuous and in-depth reforms and opening up as well as complete industrial chain and resources.
Bayer will further forge innovation and cooperation to provide leading products and services for Chinese patients, consumers and growers, empowering people to create a better life.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
